Free Trial

Vor Biopharma (VOR) SEC Filings & 10K Form

$1.06 +0.17 (+19.10%)
As of 06/27/2025

Recent Vor Biopharma SEC Filings

DateFilerForm TypeView
06/25/2025
8:18 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
4:45 PM
Namouni Fouad (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Patterson Matthew R (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Beckman Daniella (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Lubner David Charles (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Lundberg Sven Ante (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:45 PM
Resnick Joshua (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:47 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:05 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:35 AM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2025
3:30 PM
Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
11:15 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form EFFECT
03/28/2025
3:33 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form PRE 14A
03/20/2025
3:45 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:48 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:01 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
3:29 PM
Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:34 AM
FMR LLC (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
Form SCHEDULE 13G/A
02/07/2025
3:35 PM
Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:36 PM
ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:37 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:01 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
8:19 PM
Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:20 PM
Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:22 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:23 PM
ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
11:15 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form EFFECT
01/29/2025
4:24 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 424B3
01/21/2025
3:24 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2025
5:39 PM
Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:41 PM
Kalir Erez (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
8:06 AM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:53 PM
Reprogrammed Interchange LLC (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
Form SCHEDULE 13D
01/02/2025
6:37 PM
Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
6:42 PM
Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
5:51 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
Form SCHEDULE 13D/A
12/30/2024
5:52 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:17 PM
Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
8:05 AM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
12/09/2024
6:39 AM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:33 PM
Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
Form SC 13G/A
11/08/2024
3:15 PM
ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:15 PM
Quinlan Amy (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:20 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Attar Eyal C. (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM
Quinlan Amy (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
3:16 PM
Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
3:17 PM
Choi Han Wook (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:05 AM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:06 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:01 PM
Vor Biopharma Inc. (Filer)
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:29 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:30 PM
ANG ROBERT (Reporting)
Vor Biopharma Inc. (Issuer)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:04 PM
Jorgensen Nathan D. (Reporting)
Vor Biopharma Inc. (Subject)
Vor Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VOR) was last updated on 6/29/2025 by MarketBeat.com Staff
From Our Partners